Visentin, A.; Pravato, S.; Castellani, F.; Campagnolo, M.; Angotzi, F.; Cavarretta, C.A.; Cellini, A.; Ruocco, V.; Salvalaggio, A.; Tedeschi, A.;
et al. From Biology to Treatment of Monoclonal Gammopathies of Neurological Significance. Cancers 2022, 14, 1562.
https://doi.org/10.3390/cancers14061562
AMA Style
Visentin A, Pravato S, Castellani F, Campagnolo M, Angotzi F, Cavarretta CA, Cellini A, Ruocco V, Salvalaggio A, Tedeschi A,
et al. From Biology to Treatment of Monoclonal Gammopathies of Neurological Significance. Cancers. 2022; 14(6):1562.
https://doi.org/10.3390/cancers14061562
Chicago/Turabian Style
Visentin, Andrea, Stefano Pravato, Francesca Castellani, Marta Campagnolo, Francesco Angotzi, Chiara Adele Cavarretta, Alessandro Cellini, Valeria Ruocco, Alessandro Salvalaggio, Alessandra Tedeschi,
and et al. 2022. "From Biology to Treatment of Monoclonal Gammopathies of Neurological Significance" Cancers 14, no. 6: 1562.
https://doi.org/10.3390/cancers14061562
APA Style
Visentin, A., Pravato, S., Castellani, F., Campagnolo, M., Angotzi, F., Cavarretta, C. A., Cellini, A., Ruocco, V., Salvalaggio, A., Tedeschi, A., Trentin, L., & Briani, C.
(2022). From Biology to Treatment of Monoclonal Gammopathies of Neurological Significance. Cancers, 14(6), 1562.
https://doi.org/10.3390/cancers14061562